KRT19 and breast cancer: We provide, to our knowledge, the first clear evidence of a strong correlation between detection of CK-19 mRNA-positive CTC during follow-up and increased risk of late disease relapse and death in patients with either hormonal receptor positive or negative operable breast cancer.